As the U.S. turns away from its role as a global health leader, we're increasing our risks from the next pandemic.

StockNews.com assumed coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Saturday. The firm issued a hold rating on the biotechnology company’s stock.

Since 1959 the avian flu virus H5N1 has been popping up around the globe. Now scientists believe it could spark the next ...

Two American virologists with former ties to the Wuhan Institute of Virology (WIV) argue that the lab’s recent research poses ...

New research reveals that severe COVID-19 pneumonia can cause lasting lung damage, primarily due to impaired pulmonary ...

The money is Wisconsin’s share of $12 billion approved by Congress to combat infectious disease and other serious health ...

Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...

Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...